Migraine Drug Ubrogepant Tackles Debilitating Early Symptoms
Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent preheadache fatigue and light sensitivity
Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent preheadache fatigue and light sensitivity
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
